Elusive zebrafish enzyme in lipid secretion
Lipids provide energy and structural components during vertebrate development. Lipoproteins aid in lipid transport throughout the body, and synthesized lipids are also stored in lipid droplets within the cell. Embryos of the model organism zebrafish receive nutrients, including lipids, from a maternally deposited yolk through extraembryonic tissue called the yolk syncytial layer, or YSL. Lipid nutrients are released through the production and secretion of lipoproteins rich in triacylglycerol, or TAG. Scientists want to understand which enzymes direct TAG production to lipoproteins for secretion versus lipid droplets for storage.

In a recent Journal of Biological Chemistry article, Meredith Wilson from Johns Hopkins University and U.S. and U.K. colleagues investigated the fate of TAG in zebrafish lacking certain TAG synthesis enzymes. They found that zebrafish lacking diacylglycerol acyltransferase-2, or Dgat2, can still produce TAG, but the TAG is channeled for YSL storage instead of secretion, as noted by the excessive accumulation of lipid droplets in the YSL that make it look opaque.
The authors concluded that zebrafish have multiple enzymes to ensure TAG production remains intact. Future studies will identify the enzyme that fails to properly channel TAG to lipoprotein formation for secretion in embryonic development.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Building a career in nutrition across continents
Driven by past women in science, Kazi Sarjana Safain left Bangladesh and pursued a scientific career in the U.S.

Avoiding common figure errors in manuscript submissions
The three figure issues most often flagged during JBC’s data integrity review are background signal errors, image reuse and undeclared splicing errors. Learn how to avoid these and prevent mistakes that could impede publication.

Ragweed compound thwarts aggressive bladder and breast cancers
Scientists from the University of Michigan reveal the mechanism of action of ambrosin, a compound from ragweed, selectively attacks advanced bladder and breast cancer cells in cell-based models, highlighting its potential to treat advanced tumors.

Lipid-lowering therapies could help treat IBD
Genetic evidence shows that drugs that reduce cholesterol or triglyceride levels can either raise or lower inflammatory bowel disease risk by altering gut microbes and immune signaling.

Key regulator of cholesterol protects against Alzheimer’s disease
A new study identifies oxysterol-binding protein-related protein 6 as a central controller of brain cholesterol balance, with protective effects against Alzheimer’s-related neurodegeneration.

From humble beginnings to unlocking lysosomal secrets
Monther Abu–Remaileh will receive the ASBMB’s 2026 Walter A. Shaw Young Investigator Award in Lipid Research at the ASBMB Annual Meeting, March 7-10 in Washington, D.C.